Spots Global Cancer Trial Database for QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
Official Title: Phase Ia Clinical Study of Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of QLF32004 for Injection Monotherapy in Patients With Advanced Malignant Tumors
Study ID: NCT05108779
Conditions
Interventions
Study Description
Brief Summary: To determine the safety, tolerability, and recommended dose (RP2D) of QLF32004 in patients with advanced malignancies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Shanghai East Hospital, Shanghai, Shanghai, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
